Ke Men
Impact in
- Molecular Medicine top 1%
- Curcumin's Biomedical Applications
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in ⓘ
- Biomaterials 16
- Nanoparticle-Based Drug Delivery 15
- Immunology 21
- Immunotherapy and Immune Responses 14
- Co-authors
- Maling Gou (21 shared papers)Yuquan Wei (26 shared papers)Zhiyong Qian (18 shared papers)Xingmei Duan (28 shared papers)Feng Luo (12 shared papers)Jia Song (3 shared papers)Shi H (5 shared papers)Sibei Lei (14 shared papers)
- Journals
- International Journal of Nanomedicine (12 papers)Journal of Biomedical Nanotechnology (6 papers)Molecular Pharmaceutics (5 papers)Nanoscale (4 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Ke Men
79 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 124
- Molecular Medicine 382
- Biomaterials 882
- Pharmaceutical Science 271
- Immunology 431
- Molecular Biology 1.1k
Countries citing papers authored by Ke Men
This map shows the geographic impact of Ke Men's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Men with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Men more than expected).
Fields of papers citing papers by Ke Men
This network shows the impact of papers produced by Ke Men. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Men. The network helps show where Ke Men may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Men, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 348 | |
| 2 | 2012 | 147 | |
| 3 | 2009 | 100 | |
| 4 | 2009 | 96 | |
| 5 | 2011 | 91 | |
| 6 | 2019 | 81 | |
| 7 | 2010 | 80 | |
| 8 | 2022 | 78 | |
| 9 | 2009 | 76 | |
| 10 | 2020 | 73 | |
| 11 | 2010 | 73 | |
| 12 | 2012 | 67 | |
| 13 | 2009 | 66 | |
| 14 | 2020 | 63 | |
| 15 | 2021 | 62 | |
| 16 | 2016 | 60 | |
| 17 | 2008 | 57 | |
| 18 | 2014 | 54 | |
| 19 | 2023 | 48 | |
| 20 | 2019 | 47 |
About Ke Men
Ke Men is a scholar working on Biomaterials, Immunology, Rehabilitation, Molecular Medicine and Molecular Biology, having authored 82 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (37 papers), Virus-based gene therapy research (17 papers), Nanoparticle-Based Drug Delivery (15 papers), Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (11 papers), Advanced biosensing and bioanalysis techniques (8 papers), Nanoplatforms for cancer theranostics (6 papers) and Magnolia and Illicium research (6 papers). The work is most often cited by research in Molecular Medicine (382 citations), Biomaterials (882 citations), Pharmaceutical Science (271 citations), Immunology (431 citations) and Molecular Biology (1.1k citations). Ke Men has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Maling Gou, Yuquan Wei, Zhiyong Qian, Xingmei Duan, Feng Luo, Jia Song, Shi H, Sibei Lei, Gang Guo and Xueyan Zhang. Their work appears in journals such as International Journal of Nanomedicine, Journal of Biomedical Nanotechnology, Molecular Pharmaceutics, Nanoscale and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.